Business case Biopure by Simone Huygens on Prezi

 

biopure case study

Access to case studies expires six months after purchase date. Publication Date: May 29, It is early and Biopure Corp., a small biopharmaceutical firm with no sales revenues in its ten. BIOPURE CASE SUMMARY Course: Strategic Marketing Management Name: Firat Sekerli The Problem: Biopure Corporation has two new products that are Oxyglobin and Hemopure. Oxyglobin is the first new blood substitute for the veterinary market and is ready for consumer use. Hemopure is another new blood substitute for the human market and it will take. Feb 13,  · Biopure Case Study Essay Words | 12 Pages. Estimated Market Demand for Oxyglobin 13 Exhibit 3: Estimation of veterinary Market and per year 14 Exhibit 4: Financial Projections – Sensitivity Analysis 15 Executive Summary In , Biopure Corporation is one of the three legitimate contenders in the emerging field of “blood substitutes”.


Biopure - Wikipedia


Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our User Agreement and Privacy Policy. See our Privacy Policy and User Agreement for details. Published on Jul 31, SlideShare Explore Search You.

Submit Search. Successfully reported this slideshow. We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Upcoming SlideShare. Like this presentation? Why not share! Embed Size px. Start on. Show related SlideShares at end. WordPress Shortcode. Vishwa BhaskarConsultant Follow. Full Name Comment goes here. Are you sure you want to Yes No. Olga BockeriaExpert science and biotechnology - Ministry of Education and Science of Russia at Presidential council for science and education. Digital Nest at Digital Nest. Show More. No Downloads.

Views Total views. Actions Shares. Embeds 0 No embeds, biopure case study. No notes for slide. Biopure 1. Market Overview 1.

Market Overview contd. Biopure case study blood substitute which has received full governments approval. Oxyglobin B. Technological expertise which enables it to produce blood substitute with bovine RBC.

No prior expertise in launching the product and marketing, biopure case study. No self generated revenues biopure case study on date. No distribution network in place, biopure case study. No developed product, which can be delivered on spot of accidents 2.

Increase in the age of particular segment of population Hemopure 3. High Demand for blood substitutes LOW 1. No competitors in the veterinary market substitutes Success Probability AttractivenessOpportunity Matrix Option 2: Delaying the launch of Oxyglobin till hemopure is launched.

As of AprilHemopure was approved for commercial sale in South Africa for treatment of acute anemia in general surgery. You just clipped your first slide! Clipping is a handy way to collect important slides you want to go back to later. Now customize the name of a clipboard to store your clips.

Visibility Others can see my Clipboard. Cancel Save.

 

Biopure Case | Case Study Template

 

biopure case study

 

Acceptance of donated blood Possible rejection of Hemopure Little to prevent competitors Conclusion (2) Conclusion (1) The early introduction of Oxyglobin might lead to a decreased willingness to pay for Hemopure. However, the benefits of the immediate release of Oxyglobin will. Executive Summary This paper analyzes possible scenarios of Biopure’s products launching and provides marketing plan of the recommended one. The study shows that Biopure should immediately launch Oxyglobin rather than wait for Hemopure’s FDA . Pourer Corporation Case Study Pourer Corporation have two new products that are Globing and Humored. Globing is the first blood substitute for the veterinary market and is ready for launch.